Cytokinetics | CYTK - Pre Tax Profit



Cytokinetics reported $-134370000 in Pre-Tax Profit for its fiscal quarter ending in June of 2025.


Pre Tax Profit Change Date
Acadia Pharmaceuticals USD 40.21M 12.43M Jun/2025
Amgen USD 1.57B 405M Jun/2025
Bayer EUR -426000000 2.26B Jun/2025
Biogen USD 744M 432.8M Jun/2025
Bristol-Myers Squibb USD 1.77B 1.2B Jun/2025
Cytokinetics USD -134370000 27.01M Jun/2025
Eisai JPY 22.4B 22.43B Jun/2025
Eli Lilly USD 6.78B 3.32B Jun/2025
Exelixis USD 230.42M 24.72M Jun/2025
Geron USD -16375000 3.46M Jun/2025
Halozyme Therapeutics USD 204.94M 61.11M Jun/2025
Ionis Pharmaceuticals USD 124M 271M Jun/2025
Ligand Pharmaceuticals USD 39.14M 89.32M Jun/2025
Merck USD 6.77B 864M Jun/2025
Novartis USD 4.53B 124M Jun/2025
Pfizer USD 3.04B 259M Jun/2025
Regeneron Pharmaceuticals USD 1.52B 613.7M Jun/2025
Roche Holding CHF 1.78B 2.33B Dec/2024
Sanofi EUR 1.42B 734M Jun/2025